Toby Roe

489 total citations
7 papers, 302 citations indexed

About

Toby Roe is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Toby Roe has authored 7 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Toby Roe's work include Sarcoma Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Toby Roe is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Toby Roe collaborates with scholars based in United Kingdom, Germany and China. Toby Roe's co-authors include Colin S. Cooper, Jeremy Clark, Andrew Feber, Christopher S. Foster, Andrew Dodson, Cyril Fisher, S M Edwards, Alison Falconer, Penny Flohr and Janet Shipley and has published in prestigious journals such as Cancer Research, Oncogene and British Journal of Cancer.

In The Last Decade

Toby Roe

7 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toby Roe United Kingdom	4	195	116	99	77	34	7	302
Kelly A. Shimabukuro United States	9	171 0.9×	132 1.1×	120 1.2×	94 1.2×	50 1.5×	17	353
S. Gadgeel United States	5	133 0.7×	129 1.1×	67 0.7×	153 2.0×	9 0.3×	16	262
Justin A. Budka United States	8	223 1.1×	89 0.8×	77 0.8×	109 1.4×	15 0.4×	16	314
Yingke Zhou China	12	256 1.3×	154 1.3×	96 1.0×	72 0.9×	20 0.6×	17	366
Sally Turla United States	7	285 1.5×	129 1.1×	74 0.7×	76 1.0×	24 0.7×	8	399
Pamela L. Lyle United States	5	117 0.6×	123 1.1×	46 0.5×	75 1.0×	22 0.6×	6	261
Xiangshan Yang China	12	133 0.7×	76 0.7×	72 0.7×	70 0.9×	34 1.0×	21	295
Jianjun Xiao China	9	89 0.5×	115 1.0×	75 0.8×	72 0.9×	16 0.5×	16	222
Xiang Ma China	13	281 1.4×	66 0.6×	253 2.6×	82 1.1×	35 1.0×	26	435

Countries citing papers authored by Toby Roe

Since Specialization

Citations

This map shows the geographic impact of Toby Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby Roe more than expected).

Fields of papers citing papers by Toby Roe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby Roe. The network helps show where Toby Roe may publish in the future.

Co-authorship network of co-authors of Toby Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Toby Roe. A scholar is included among the top collaborators of Toby Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby Roe. Toby Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Powers, Marissa, Swee Y. Sharp, Toby Roe, et al.. (2024). Abstract 524: Using acquired resistance to explore the mechanism of action of the integrated stress response/GCN2 activator NXP800 - A new developmental agent for platinum-resistant ARID1A mutant ovarian cancer. Cancer Research. 84(6_Supplement). 524–524. 2 indexed citations

2.

Powers, Marissa, Swee Y. Sharp, Toby Roe, et al.. (2023). Abstract LB234: Activation of the integrated stress response by the developmental HSF1 pathway inhibitor NXP800. Cancer Research. 83(8_Supplement). LB234–LB234. 3 indexed citations

3.

Clarke, Paul A., Toby Roe, Steve Hobbs, et al.. (2019). Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer. Oncogene. 38(25). 5076–5090. 29 indexed citations

4.

Lee, Yin-Fai, Toby Roe, D. Chas Mangham, et al.. (2016). Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance. British Journal of Cancer. 115(8). 1000–1007. 3 indexed citations

5.

Cooper, Colin S., Andrew G. Nicholson, Christopher S. Foster, et al.. (2006). Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer. 54(2). 155–162. 74 indexed citations

6.

Lee, Yin-Fai, Alison Falconer, S M Edwards, et al.. (2004). A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas. Cancer Research. 64(20). 7201–7204. 59 indexed citations

7.

Feber, Andrew, Jeremy Clark, Graham H. Goodwin, et al.. (2003). Amplification and overexpression of E2F3 in human bladder cancer. Oncogene. 23(8). 1627–1630. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact